BridgeMD
New treatment option for Visual Field Loss
Official title Motor Performance Improvement After Visual Rehabilitation
ClinicalTrials.gov ID: NCT06698172
What this study is testing
- What it's testing
- Acquired brain injury" refers to brain damage that impacts neurological processing, making daily activities challenging and often causing vision issues like binocular dysfunction, oculomotor problems, and visual field loss. In Spain, visual rehabilitation is limited, although it is more common in other countries.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adult people diagnosed with acquired brain injury either from a stroke or trauma.
- people without cognitive impairment.
- people without pre-existing musculoskeletal disorders prior to the acquired brain injury.
- people without hemineglect.
- people with more than 6 months of progression since the brain injury.
You likely can't join if
- Not signing the informed consent.
- Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
- Uncontrolled epilepsy.
- people with glaucoma or retinal pathologies affecting the visual field.
- people with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
- people who are not stable in any associated clinical pathology or otherwise diagnosed.
See the full eligibility criteria
- Adult people diagnosed with acquired brain injury either from a stroke or trauma.
- people without cognitive impairment.
- people without pre-existing musculoskeletal disorders prior to the acquired brain injury.
- people without hemineglect.
- people with more than 6 months of progression since the brain injury.
- people who have an electronic device such as a computer and internet access to perform the exercises at home.
- people with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.
- Not signing the informed consent.
- Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
- Uncontrolled epilepsy.
- people with glaucoma or retinal pathologies affecting the visual field.
- people with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
- people who are not stable in any associated clinical pathology or otherwise diagnosed.
- people who have previously undergone visual rehabilitation for the field defect.
- Not performing the proposed home exercises.
The study team makes the final eligibility decision.
Where it's taking place
- Zaragoza, Zaragoza, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zaragoza, Zaragoza, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.